28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 6800 - 7000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1471 | Other Disorders of Optic Nerve | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1473 | Other Endophthalmitis | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1475 | Prior Penetrating Keratoplasty | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1477 | Purulent Endophthalmitis | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1478 | Retinal Detachment with Retinal Defect | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1479 | Retinal Vascular Occlusion | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1480 | Other Proliferative Retinopathy | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1482 | Separation of Retinal Layers | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1483 | Visual Acuity 20/40 or Better | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1491 | Major Depressive Disorder Active | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1492 | Psych Visit Diagnostic Evaluation | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1496 | Psych Visit Psychotherapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1530 | Speech and Hearing Evaluation | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1558 | Morgagnian Cataract | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1559 | Macular Scar of Posterior Polar | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1560 | Best Corrected Visual Acuity Exam Using Snellen Chart | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1561 | Medications for Above Normal BMI | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1562 | Medications for Below Normal BMI | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1563 | Underweight | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1566 | Adult Depression Medications | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1567 | Adolescent Depression Medications | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1568 | Follow Up for Adult Depression | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1569 | Follow Up for Adolescent Depression | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1570 | Referral for Adolescent Depression | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1571 | Referral for Adult Depression | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1572 | High Intensity Statin Therapy | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1573 | LDL Cholesterol | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1574 | Low Intensity Statin Therapy | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1575 | Moderate Intensity Statin Therapy | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1576 | Outpatient Encounters for Preventive Care | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1578 | Follow Up Within 4 Weeks | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1580 | Referral to Primary Care or Alternate Provider | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1581 | Lifestyle Recommendation | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1582 | Patient Declined | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1583 | Referral or Counseling for Alcohol Consumption | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1584 | Hospice Care Ambulatory | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.3000 | Metformin | active | 2019-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.319 | Prostate Cancer | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.320 | Bone Scan | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.326 | Primary Open Angle Glaucoma | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.327 | Diabetic Retinopathy | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.353 | End Stage Renal Disease | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.362 | Asthma | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.366 | Arrhythmia | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.367 | Atrioventricular Block | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.368 | Cardiac Pacer in Situ | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.369 | Coronary Artery Disease No MI | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.370 | Hypotension | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.371 | Cardiac Surgery | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.376 | Heart Failure | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.378 | Pregnancy | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.398 | Prostate Cancer Treatment | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.399 | Salvage Therapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.401 | Prostate Specific Antigen Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.403 | Initial Myocardial Infarction | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.412 | Bradycardia | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.451 | Pain Warranting Further Investigation for Prostate Cancer | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.471 | Bilateral Oophorectomy | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.485 | Chemotherapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.509 | Tobacco Use Cessation Counseling | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1498 | Medications for Above Normal BMI | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1499 | Medications for Below Normal BMI | active | 2022-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1519 | Follow Up for Above Normal BMI | active | 2017-05 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1523 | Follow Up for Above Normal BMI | active | 2017-08 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1524 | Follow Up for BMI Outside Normal Parameters | active | 2024-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1525 | Follow Up for Above Normal BMI | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1526 | Follow Up for Above Normal BMI | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1527 | Referrals Where Weight Assessment May Occur | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1528 | Follow Up for Below Normal BMI | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1549 | Follow Up for Below Normal BMI | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1550 | Follow Up for Below Normal BMI | active | 2023-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1551 | Follow Up for Below Normal BMI | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1578 | Palliative Care | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1579 | Palliative or Hospice Care | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1608 | Encounter to Document Medications | active | 2025-01 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1609 | Encounter to Document Medications | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1610 | Referrals Where Weight Assessment May Occur | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1751 | Encounter to Evaluate BMI | active | 2024-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1834 | Encounter to Document Medications | active | 2024-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1917 | Encounter to Document Medications | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.695 | Encounter to Evaluate BMI | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.885 | Encounter to Evaluate BMI | active | 2018-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.886 | Encounter to Evaluate BMI | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1475 | Referral to Primary Care or Alternate Provider | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1476 | Pharmacologic Therapy for Hypertension | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1482 | Laboratory Tests for Hypertension | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1497 | Encounter to Screen for Blood Pressure | active | 2024-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1508 | Lifestyle Recommendation | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1509 | Weight Reduction Recommended | active | 2022-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1510 | Weight Reduction Recommended | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1511 | Dietary Recommendations | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1512 | Dietary Recommendations | active | 2025-01 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1514 | Dietary Recommendations | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1515 | Dietary Recommendations | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1516 | Exercise Class | active | 2017-05 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1518 | Recommendation to Increase Physical Activity | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1537 | Follow Up Within 4 Weeks | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1538 | Encounter to Screen for Depression | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1914 | Encounter to Screen for Depression | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1915 | Encounter to Screen for Depression | active | 2023-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1916 | Encounter to Screen for Depression | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1918 | Encounter to Screen for Blood Pressure | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.192 | Encounter to Screen for Blood Pressure | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1920 | Encounter to Screen for Blood Pressure | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2387 | Overweight or Obese | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2388 | Underweight | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2395 | Finding of Hypertension | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2462 | Laboratory Tests for Hypertension | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2466 | Dental Tooth Extraction | active | 2022-02 | us | hl7 | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.259 | Diagnosis of Hypertension | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.261 | Diagnosis of Hypertension | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.263 | Diagnosis of Hypertension | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.467 | Follow Up for Adolescent Depression | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.468 | Follow Up for Adult Depression | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.469 | Adolescent Depression Medications | active | 2023-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.470 | Adult Depression Medications | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.537 | Referral for Adolescent Depression | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.538 | Referral for Adult Depression | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.791 | Patient Declined | active | 2025-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.805 | Weight Reduction Recommended | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.810 | Recommendation to Increase Physical Activity | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.823 | Referral or Counseling for Alcohol Consumption | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.6366.117 | Absence of Cervix | active | 2024-08 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.1743 | General or Neuraxial Anesthesia | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.1940 | Immunocompromised Conditions | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2262 | CABG Surgeries | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2328 | Immunocompromised Conditions I10 | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2343 | Immunocompromised Conditions | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.3011 | Acute Myocardial Infarction | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.3024 | Acute Myocardial Infarction | active | 2016-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.307 | Encounter Inpatient | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.335 | Bone Marrow Transplant | active | 2021-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.336 | Bone Marrow Transplant | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.404 | Bone Marrow Transplant | active | 2024-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.623 | Acute Myocardial Infarction | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.694 | CABG Surgeries | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.737 | PCI | active | 2018-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.747 | Endotracheal Intubation | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.128 | Bipolar Disorder | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.246 | Personality Disorder Emotionally Labile | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.247 | Personality Disorder Emotionally Labile | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.248 | Personality Disorder Emotionally Labile | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.249 | Personality Disorder Emotionally Labile | active | 2023-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.254 | Dysthymia | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.256 | Dysthymia | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.257 | Dysthymia | active | 2023-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.262 | Deceased | active | 2014-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.263 | PHQ 9 and PHQ 9M Tools | active | 2022-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.269 | Hepatitis B | active | 2017-08 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.271 | Hepatitis B | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.272 | Hepatitis B | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.43 | Bipolar Disorder | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.44 | Bipolar Disorder | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.45 | Bipolar Disorder | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.11.721 | Deceased | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.11.723 | PHQ-9 Tool | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.2.1000 | Estimated Glomerular Filtration Rate | active | 2024-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.2.1002 | Urine Albumin Creatinine Ratio | active | 2025-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.3.1000 | Estimated Glomerular Filtration Rate | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.3.1007 | Urine Albumin Creatinine Ratio | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1000 | Strabismic Amblyopia | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1001 | Strabismic Amblyopia | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1002 | Refractive Amblyopia | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1003 | Refractive Amblyopia | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1004 | Routine Ophthalmological Examination | active | 2019-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1005 | Pediatric Best Corrected Visual Acuity Exam | active | 2019-09 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1006 | LogMAR Visual Acuity Exam | active | 2019-09 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1007 | Aphakia | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1008 | Aphakia | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1009 | Infantile and Juvenile Cataract | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1010 | Infantile and Juvenile Cataract | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1011 | Congenital Corneal or Anterior Segment Conditions | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1012 | Congenital Corneal or Anterior Segment Conditions | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1013 | Eyelid or Orbital Conditions | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1014 | Eyelid or Orbital Conditions | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1015 | Coloboma of Optic Disc | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1016 | Coloboma of Optic Disc | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1017 | Hemorrhage of Optic Nerve Sheath | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1018 | Hemorrhage of Optic Nerve Sheath | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1019 | Optic Nerve Hypoplasia | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1020 | Optic Nerve Hypoplasia | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1021 | Disorder of Visual Cortex Due to Underlying Condition | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1022 | Disorder of Visual Cortex Due to Underlying Condition | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1023 | Cortical Blindness | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1024 | Cortical Blindness | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1025 | Congenital Condition of Retina | active | 2019-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1026 | Congenital Condition of Retina | active | 2019-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1000 | Strabismic Amblyopia | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1001 | Refractive Amblyopia | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1002 | Routine Ophthalmological Examination | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1003 | Pediatric Best Corrected Visual Acuity Exam | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1004 | LogMAR Visual Acuity Exam | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1005 | Aphakia | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1006 | Infantile and Juvenile Cataract | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1007 | Congenital Corneal or Anterior Segment Conditions | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1008 | Eyelid or Orbital Conditions | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1009 | Coloboma of Optic Disc | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1010 | Hemorrhage of Optic Nerve Sheath | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1011 | Optic Nerve Hypoplasia | active | 2019-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1012 | Disorder of Visual Cortex Due to Underlying Condition | active | 2019-09 | us | hl7 | vsac |